Brookfield Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-29,626
| Closed | -$21.3M | – | 434 |
|
|
2023
Q2 | $21.3M | Buy |
29,626
+2,366
| +9% | +$1.7M | 0.08% | 87 |
|
|
2023
Q1 | $22.4M | Buy |
27,260
+9,349
| +52% | +$7.68M | 0.09% | 90 |
|
|
2022
Q4 | $12.9M | Buy |
17,911
+2,886
| +19% | +$2.08M | 0.05% | 124 |
|
|
2022
Q3 | $10.4M | Buy |
+15,025
| New | +$10.4M | 0.04% | 153 |
|